4.2 Article

Highlights of the 33rd annual scientific meeting of the Association of Medical Laboratory Immunologists (AMLI)

Journal

JOURNAL OF IMMUNOLOGICAL METHODS
Volume 492, Issue -, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.jim.2021.112994

Keywords

Histocompatibility; Immune monitoring; Immunodeficiency; Immunotherapy; Antinuclear antibodies; COVID-19

Ask authors/readers for more resources

The AMLI annual meeting was held virtually in August with topics covering histocompatibility testing, immunotherapy monitoring, and more. To address the COVID-19 pandemic, a session on antibody testing for SARS-CoV-2 infections was added to the program.
The annual meeting of the Association of Medical Laboratory Immunologists (AMLI) was convened virtually over the month of August. Prior to the emergence of the COVID-19 pandemic, AMLI's scientific committee had chosen the following topics as the focus of its 2020 meeting: Histocompatibility Testing and Transplant Immunology; Secondary Immunodeficiency and Immunotherapy Monitoring; ANA Update; and Emerging Infectious Diseases and New Algorithms for Testing. Given the central role of the discipline in the evaluation of the host response to infection, it was apt to add a separate session on antibody testing for SARS-CoV-2 infections to the original program. The current report provides an overview of the subjects discussed in the course of this meeting.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available